Ponatinib T2372
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ponatinib is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5/2.2/5.4 nM for Abl, PDGFR_, VEGFR2, FGFR1, and Src, respectively).
CAS nr:
943319-70-8
Purity:
98%
Molecular Weight:
532,56
SMILES:
CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1
Formula:
C29H27F3N6O
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Autophagy,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling
Target:
PDGFR,PDGFR,VEGFR,VEGFR,Src,Src,Autophagy,FGFR,FGFR,c-Kit,Bcr-Abl,Bcr-Abl,Bcr-Abl
